Form 4: Amphastar Pharmaceuticals Director Sells 3,000 Shares
SEC Form 4 Filing
Floyd F. Petersen, a director at Amphastar Pharmaceuticals, sold 3,000 shares of common stock at $41.40 per share on June 10, 2024.
Summary
- On June 10, 2024, Floyd F. Petersen, a director of Amphastar Pharmaceuticals, Inc., sold 3,000 shares of the company's common stock.
- The sale price was $41.40 per share.
- Following the transaction, Petersen directly owns 78,409 shares of Amphastar Pharmaceuticals.
Sentiment
Score: 5
Explanation: The document simply reports a stock sale by a director, which is a neutral event. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This is a routine disclosure of insider trading activity. It's important to monitor such filings to understand the sentiment of company insiders.
Stakeholder Impact
- The sale of shares by a director could be perceived negatively by some shareholders, potentially leading to a slight decrease in stock price, although the volume is relatively small.
Key Dates
| Date | Description |
|---|---|
| 06/10/2024 | Date of stock sale transaction |
| 06/11/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.